Cargando…

Frequent Ischemic Stroke as First Manifestation of Occult Colon Cancer: A Rare Case

Patient: Male, 46 Final Diagnosis: Adenocarcinoma of the ascending colon Symptoms: Anemia • diplopia • hemiparesis • slurred speech Medication: — Clinical Procedure: Multi-detector computed tomography • colonoscopy Specialty: Neurology OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chia-Chan, Wu, Meng-Ni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610689/
https://www.ncbi.nlm.nih.gov/pubmed/26460069
http://dx.doi.org/10.12659/AJCR.895130
Descripción
Sumario:Patient: Male, 46 Final Diagnosis: Adenocarcinoma of the ascending colon Symptoms: Anemia • diplopia • hemiparesis • slurred speech Medication: — Clinical Procedure: Multi-detector computed tomography • colonoscopy Specialty: Neurology OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: It is rare that occult cancer presents with frequent ischemic stroke as the sole manifestation. CASE REPORT: We report the case of a 46-year-old man with frequent stroke in different vascular areas, with diabetes and hypercholesterolemia identified as risk factors. The results of biochemistry, young stroke profiles, trans-cranial and extra-cranial carotid Doppler, and 24-h Holter electrocardiogram were within normal limits. The reports of transthoracic echocardiography (TTE) were unremarkable. Finally, a multi-detector computed tomography (MDCT) demonstrated a thrombus in the posterior-lateral aspect of the left atrium and non-bacterial thrombotic endocarditis (NBTE) was suspected. The results motivated the survey for occult cancer, and adenocarcinoma of the ascending colon was confirmed on colonoscopy pathology. CONCLUSIONS: We suggest that evaluating the possibility of occult cancer should be emphasized in patients of frequent stroke refractory to therapy, whether risk factors are already identified or not. Furthermore, we assume MDCT can be an alternative way to detect cardiogenic embolic sources in stroke patients.